HM-12460A

N/A

Report date: 2025/12/05 16:19:12

Base Information

Drug NameHM-12460A

Drug Alias Name长效胰岛素LAPS-Insulin - Hanmi PharmaceuticalUltra-Long Acting Insulin - Hanmi PharmaceuticalInsulin long-acting （Hanmi Pharmaceutical）LAPSInsulin (Hanmi Pharmaceutical) +[7]

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant hormone

Mechanisms of ActionInsulin receptor agonists

TargetsInsulin receptor

Therapy Area/IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusDiscontinued (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesHanmi Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesHanmi Pharmaceutical Co Ltd

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2Diabetes Mellitus, Type 1

Other Information

ATC CodeN/A